Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus

被引：312
|
作者：
Abbasi, F [1 ]
Asagmi, T [1 ]
Cooke, JP [1 ]
Lamendola, C [1 ]
McLaughlin, T [1 ]
Reaven, GM [1 ]
Stuehlinger, M [1 ]
Tsao, PS [1 ]
机构：
[1] Stanford Univ, Med Ctr, Sch Med, Falk CVRC,Div Cardiovasc Med, Stanford, CA 94305 USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2001年 / 88卷 / 10期
关键词：
D O I：
10.1016/S0002-9149(01)02063-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Increased risk of coronary heart disease in patients with type 2 diabetes cannot be accounted for by differences in conventional risk factors. This study demonstrates that plasma concentrations of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, are increased in patients with type 2 diabetes, thereby identifying a new and potentially important coronary heart disease risk factor in this patient population.
引用
收藏
页码：1201 / +
页数：4
相关论文
共 50 条
  • [21] Metformin attenuates plasma asymmetric dimethylarginine and monocyte adhesion in type 2 diabetes
    Asagami, T
    Stuehlinger, MC
    Li, W
    Abbasi, FA
    Tsao, PS
    Cooke, JP
    Reaven, GM
    CIRCULATION, 2000, 102 (18) : 232 - 232
  • [22] Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes
    Krzyzanowska, Katarzyna
    Mittermayer, Friedrich
    Wolzt, Michael
    Schernthaner, Guntram
    DIABETES CARE, 2007, 30 (07) : 1834 - 1839
  • [23] Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus
    Kelly, Aaron S.
    Thelen, Andrea M.
    Kaiser, Daniel R.
    Gonzalez-Campoy, J. Michael
    Bank, Alan J.
    VASCULAR MEDICINE, 2007, 12 (04) : 311 - 318
  • [24] Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus
    Oguz, Aytekin
    Uzunlulu, Mehmet
    Yorulmaz, Elif
    Yalcin, Yavuz
    Hekim, Nezih
    Fici, Francesco
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2007, 7 (04): : 383 - 387
  • [25] Increased Resistin Serum Concentrations in Patients with Type 1 Diabetes Mellitus
    Geyikli, Iclal
    Keskin, Mehmet
    Kor, Yilmaz
    Akan, Muslum
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2013, 5 (03) : 189 - 193
  • [26] Plasma levels of asymmetric dimethylarginine are increased in patients with essential hypertension
    Gkaliagkousi, E.
    Zamboulis, C.
    Douma, S.
    Ritter, J.
    Ferro, A.
    JOURNAL OF HYPERTENSION, 2008, 26 : S314 - S314
  • [27] CTGF plasma concentrations correlate with plasma creatinine concentrations in patients with type 1 diabetes mellitus
    不详
    JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (05) : 472 - 473
  • [28] The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with type 2 diabetes mellitus
    Jung, HS
    Youn, BS
    Cho, YM
    Yu, KY
    Park, HJ
    Shin, CS
    Kim, SY
    Lee, HK
    Park, KS
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (03): : 314 - 320
  • [29] Changes in the system of asymmetric dimethylarginine - endothelial NO-synthase in patients with acute myocardial infarction and type 2 diabetes mellitus
    Minukhina, D., V
    Babadzhan, V. D.
    Kravchun, P. H.
    Minukhin, V. V.
    ZAPOROZHYE MEDICAL JOURNAL, 2018, (06) : 746 - 751
  • [30] Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow
    Selcuk, Mehmet Timur
    Selcuk, Hatice
    Temizhan, Ahmet
    Maden, Orhan
    Ulupinar, Hakan
    Baysal, Erkan
    Ozeke, Oman
    Sasmaz, Ali
    CORONARY ARTERY DISEASE, 2007, 18 (07) : 545 - 551
12345